According to Medifast's latest financial reports the company's current revenue (TTM ) is HK$5.24 Billion. In 2023 the company made a revenue of HK$8.37 Billion a decrease over the revenue in the year 2022 that were of HK$12.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | HK$5.26 B | -37.11% |
2023 | HK$8.37 B | -32.96% |
2022 | HK$12.49 B | 4.96% |
2021 | HK$11.89 B | 64.2% |
2020 | HK$7.24 B | 30.39% |
2019 | HK$5.55 B | 41.67% |
2018 | HK$3.92 B | 66.52% |
2017 | HK$2.35 B | 10.67% |
2016 | HK$2.12 B | 0.7% |
2015 | HK$2.11 B | 2.14% |
2014 | HK$2.06 B | -25.2% |
2013 | HK$2.76 B | 0.09% |
2012 | HK$2.76 B | 19.38% |
2011 | HK$2.31 B | 15.55% |
2010 | HK$2.00 B | 53.3% |
2009 | HK$1.30 B | 60.46% |
2008 | HK$0.81 B | 24.74% |
2007 | HK$0.65 B | 13.37% |
2006 | HK$0.57 B | 85.19% |
2005 | HK$0.31 B | 46.44% |
2004 | HK$0.21 B | 8% |
2003 | HK$0.19 B | 104.33% |
2002 | HK$96.27 M | 145.85% |
2001 | HK$39.15 M | 28.81% |
2000 | HK$30.4 M |